SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001012168-96-000025
Filing Date
1996-12-23
Accepted
1996-12-23 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A 50644
  Complete submission text file 0001012168-96-000025.txt   52658
Mailing Address
Business Address 1375 CALIFORNIA AVENUE P O BOX 10051 PALO ALTO CA 94303 4154968203
THERAPEUTIC DISCOVERY CORP (Subject) CIK: 0000899753 (see all company filings)

IRS No.: 943173191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45501 | Film No.: 96685159
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231